Incidences, risk factors and outcomes of neonatal thromboembolism

被引:25
作者
Sirachainan, Nongnuch [1 ]
Limrungsikul, Anchalee [1 ]
Chuansumrit, Ampaiwan [1 ]
Nuntnarumit, Pracha [1 ]
Thampratankul, Lunliya [1 ]
Wangruangsathit, Somporn [2 ]
Sasanakul, Werasak [1 ]
Kadegasem, Praguywan [1 ]
机构
[1] Mahidol Univ, Fac Med, Depatment Pediat, Ramathibodi Hosp, Bangkok, Thailand
[2] Buddhachinaraj Hosp, Dept Pediat, Phitsanulok, Thailand
关键词
Neonate; thromboembolism; risk factors; outcome; protein C deficiency; VENOUS THROMBOEMBOLISM; THROMBOSIS; CHILDREN; REGISTRY; INFANTS;
D O I
10.1080/14767058.2017.1285892
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The incidences of thromboembolism (TE) in neonates were reported to be around 0.51 per 10,000 live births per year for overall TE and 24 per 10,000 NICU admissions per year. As the incidences of TE in children and adults are lower in Asian populations, the incidences, risk factors, and outcomes of neonatal TE may be different to those reports from other countries.Objectives: To determine the incidences, risk factors, and outcomes of neonatal TE in a tertiary care hospital in Thailand.Materials and methods: A retrospective study between the years 1998 and 2015.Results: From a total of 2463 neonatal admissions, 28 patients were diagnosed with TE. The female/male ratio was 1:1.2. The breakdown of diagnoses of neonatal TE were arterial ischemic stroke (AIS; 36%), arterial TE (ATE; 29%), deep vein thrombosis (DVT; 14%), cerebral venous sinus thrombosis (CVST; 11%), renal vein thrombosis (RVT; 3%), and purpura fulminans (2%). Underlying diseases were identified 57.1% of patients. The most common thrombophilic risk factor was protein C (PC) deficiency (14.3%). The overall mortality rate was 14.3%.Conclusion: The most common TE was AIS. PC deficiency was the most prevalent inherited risk factor, especially in neonates without precipitating factors.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 15 条
  • [1] Akkawat Benjaporn, 2005, J Med Assoc Thai, V88 Suppl 4, pS249
  • [2] VENOUS THROMBOEMBOLIC COMPLICATIONS (VTE) IN CHILDREN - FIRST ANALYSES OF THE CANADIAN REGISTRY OF VTE
    ANDREW, M
    DAVID, M
    ADAMS, M
    ALI, K
    ANDERSON, R
    BARNARD, D
    BERNSTEIN, M
    BRISSON, L
    CAIRNEY, B
    DESAI, D
    GRANT, R
    ISRAELS, S
    JARDINE, L
    LUKE, B
    MASSICOTTE, P
    SILVA, M
    [J]. BLOOD, 1994, 83 (05) : 1251 - 1257
  • [3] Angchaisuksiri P, 2000, AM J HEMATOL, V65, P119, DOI 10.1002/1096-8652(200010)65:2<119::AID-AJH5>3.3.CO
  • [4] 2-#
  • [5] Bacciedoni V, 2016, ARCH ARGENT PEDIATR, V114, P159, DOI [10.5546/aap.2016.eng.159, 10.5546/aap.2016.159]
  • [6] Maternal thrombophilia and neonatal thrombosis
    Heller, C
    Nowak-Göttl, U
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (02) : 333 - 345
  • [7] Millichap J Gordon, 2015, Pediatr Neurol Briefs, V29, P36, DOI 10.15844/pedneurbriefs-29-5-3
  • [8] Antithrombotic Therapy in Neonates and Children Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Monagle, Paul
    Chan, Anthony K. C.
    Goldenberg, Neil A.
    Ichord, Rebecca N.
    Journeycake, Janna M.
    Nowak-Goettl, Ulrike
    Vesely, Sara K.
    [J]. CHEST, 2012, 141 (02) : E737S - E801S
  • [9] Neonatal symptomatic thromboembolism in Germany: Two year survey
    NowakGottl, U
    vonKries, R
    Gobel, U
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 76 (03): : F163 - F167
  • [10] Perinatal thrombosis: implications for mothers and neonates
    O'Brien, Sarah H.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 48 - 52